Editorial : "Cardiotoxicity Induced by Radiotherapy and/or Chemotherapy After Cancer Treatment " - IRSN - Institut de radioprotection et de sûreté nucléaire Accéder directement au contenu
Article Dans Une Revue Frontiers in Oncology Année : 2022

Editorial : "Cardiotoxicity Induced by Radiotherapy and/or Chemotherapy After Cancer Treatment "

Résumé

It is our privilege to present 11 articles in this Frontiers Oncology Research Topic on "cardiotoxicity induced by radiotherapy and/or chemotherapy after cancer treatment". The therapeutic management of cancer has progressed over the last 10 years and has led to a significant increase in patient survival rates. Radiotherapy (RT) is classically applied in multiple fractions administered over several weeks to kill cancer while sparing normal tissue as much as possible. However, the corollary is the development of delayed toxicities that alter the quality of life of patients. Chemo- and/or RT-induced cardiovascular disease (CVD) is recognized as a worrisome side effect in patients with thoracic cancers.

Domaines

Cancer
Fichier principal
Vignette du fichier
Editorial on the Research Topic 02 11 22 .pdf (171.07 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Licence : CC BY - Paternité

Dates et versions

irsn-04072771 , version 1 (18-04-2023)

Licence

Paternité

Identifiants

Citer

Marjan Boerma, Omid Azimzadeh, Nadia Pasinetti, Virginie Monceau. Editorial : "Cardiotoxicity Induced by Radiotherapy and/or Chemotherapy After Cancer Treatment ". Frontiers in Oncology, 2022, 12, ⟨10.3389/fonc.2022.1087928⟩. ⟨irsn-04072771⟩
5 Consultations
34 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More